The University of Cambridge Metabolic Research Laboratories has offered a series of new findings developed around using synthetic pancreases in outpatients suffering with diabetes. The idea is that the artificial organ doesn't replace the living one, but rather ensures that insulin is properly delivered by creating a specialized system that monitors glucose levels via a smartphone.
The synthetic pancreas is a constructed organ designed to do everything the living version does -- but better. The device is tech-connected and able to collect data and information on insulin levels, as well as administer more if the body is lacking. This happens automatically as a way to save lives and increase functionality in the overall body by detecting deficiencies.
Artificial Outpatient Organs
This Synthetic Pancreas Will be Aid Those Suffering With Diabetes
Trend Themes
1. Artificial Outpatient Organs - Synthetic organs that automatically monitor and administer insulin to patients with diabetes, improving their health outcomes and quality of life.
2. Personalized Health Technology - Healthcare technology that is personalized and connected to smartphones, allowing patients to monitor and manage their health in real-time.
3. Medical Iot Devices - Medical IoT devices that collect and analyze healthcare data to provide personalized treatment options and support patient outcomes.
Industry Implications
1. Healthcare - Innovative solutions in the healthcare industry that improve patient outcomes, such as personalized synthetic organs and health monitoring systems.
2. Medical Devices - Emerging medical device technologies that use IoT sensors and data analysis to increase functionality, such as artificial organs that monitor glucose levels in real-time.
3. Pharmaceuticals - Pharmaceutical companies that focus on developing personalized treatment options for chronic diseases such as diabetes, enabling patients to better manage their symptoms and improve their quality of life.